rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-9-7
|
pubmed:databankReference |
|
pubmed:abstractText |
Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in chronic obstructive pulmonary disease (COPD). The 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine (PCV7) induces a more robust immune response than PPSV23 in healthy elderly adults.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074407,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074408,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074409,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074416,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074418,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074422,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074422-01,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074422-02,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074422-03,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074422-04,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074424,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074428,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074431,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074439,
http://linkedlifedata.com/resource/pubmed/grant/U10 HL074441
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1535-4970
|
pubmed:author |
pubmed-author:AnthonisenNicholas RNR,
pubmed-author:BaileyWilliam CWC,
pubmed-author:COPD Clinical Research Network,
pubmed-author:ConnettJohn EJE,
pubmed-author:CrinerGerard JGJ,
pubmed-author:DransfieldMark TMT,
pubmed-author:HanMeilan KMK,
pubmed-author:HarndenSarahS,
pubmed-author:MartinezFernando JFJ,
pubmed-author:NahmMoon HMH,
pubmed-author:ScanlonPaul DPD,
pubmed-author:WashkoGeorge RGR,
pubmed-author:WoodruffPrescott GPG
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
180
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
499-505
|
pubmed:dateRevised |
2010-12-3
|
pubmed:meshHeading |
pubmed-meshheading:19556517-Adult,
pubmed-meshheading:19556517-Age Factors,
pubmed-meshheading:19556517-Aged,
pubmed-meshheading:19556517-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19556517-Female,
pubmed-meshheading:19556517-Humans,
pubmed-meshheading:19556517-Immunoglobulin E,
pubmed-meshheading:19556517-Male,
pubmed-meshheading:19556517-Middle Aged,
pubmed-meshheading:19556517-Pneumococcal Vaccines,
pubmed-meshheading:19556517-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:19556517-Smoking,
pubmed-meshheading:19556517-Streptococcus pneumoniae
|
pubmed:year |
2009
|
pubmed:articleTitle |
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
|
pubmed:affiliation |
Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. mdransfield99@msn.com
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|